Figure 1.

Comparisons of mortality in participants who completed the intervention period and late-onset CMV DNAemia in donor-seropositive, recipient-seronegative liver transplant recipients. A, Kaplan–Meier survival curve of participant who survived and completed the assigned intervention. B, Kaplan–Meier survival curve of participants who survived to 12 months post-transplant. C, Comparison of percent of participants who developed CMV DNAemia at 6 months and 12 months post-transplant. Analysis was limited to participants who survived to 12 months post-transplant. D, Violin plots of CMV DNAemia showing distribution of log₁₀ (CMV viral load) at 6 and 12 months post-transplant in participants who survived to 12 months post-transplant. Abbreviations: CMV, cytomegalovirus; PET, preemptive therapy; tx, treatment.